427 Rehab Centers in
Xanax
Inpatient and Outpatient Xanax Addiction Treatment in Tennessee
Xanax dependency can develop even with prescribed use, often calling for a carefully managed detox process and continued support. Look through the Tennessee providers below, featuring residential rehab centers, outpatient clinics, benzodiazepine withdrawal programs, and licensed mental health counselors.
From structured inpatient care to flexible outpatient sessions, our directory helps you find the right Xanax recovery fit in Tennessee. Each listing has been human-vetted by our quality raters to verify credentials, authenticity, and consistent service standards.
Why Trust Treatmenttennessee
Evidence and ethics matter to us. Since 2025, our expert team has built comprehensive resources you can trust to find the right treatment for you.
Unbiased and independent resource
100% editorially independent with no provider affiliations.
Accurate & comprehensive information
Comprehensive provider profiles backed by 1+ years of research.
We are trusted by millions
Helped more than 100+ families with recovery.
We adhere to ethical standards
Direct provider connections; we don’t profit from referrals.
Explore Popular Rehab Centers
Virtual Outpatient (Telehealth)

Cedar Recovery Shelbyville
Shelbyville, TN 37160
Accepts Insurance
Cedar Recovery is a well-established facility dedicated to supporting individuals on their journey to recovery. The center provides a structured, compassionate environment that prioritizes personalized….
Best Addiction & Mental Health Treatment Rehab Facilities by Xanax
Why Trust TreatmentTennessee
Evidence and ethics matter to us. Since 2025, our expert team has built comprehensive resources you can trust to find the right treatment for you.
Unbiased and independent resource
100% editorially independent with no provider affiliations.
Accurate & comprehensive information
Comprehensive provider profiles backed by 1+ years of research.
We are trusted by millions
Helped more than 100+ families with recovery.
We adhere to ethical standards
Direct provider connections; we don’t profit from referrals.
Xanax (Alprazolam) Use Disorder in Tennessee
Understanding physical dependence, withdrawal, co-occurring anxiety disorders, and evidence-based treatment options across Tennessee.
Xanax is the widely recognized brand name for alprazolam, a short-acting benzodiazepine that has been prescribed in the United States since 1981. Physicians most commonly prescribe it for generalized anxiety disorder, panic disorder, and anxiety linked to depression. Because alprazolam acts rapidly on the central nervous system — producing feelings of calm within 15 to 30 minutes — it carries a clinically recognized potential for physical dependence, even among people who take it exactly as directed by a prescribing clinician.
Tennessee has seen significant concern around benzodiazepine use alongside the state’s ongoing opioid crisis. Benzodiazepines and opioids are frequently involved together in overdose deaths because both suppress respiratory drive. Understanding what distinguishes benzodiazepine use disorder broadly from Xanax use disorder specifically — in terms of onset, withdrawal timeline, and treatment approach — is important for people in Tennessee who are looking for the right level of care.
This article focuses entirely on Xanax (alprazolam) and does not simply repeat information that applies generically to all benzodiazepines or all sedatives. The pharmacology, clinical patterns, and community resources discussed below are specific to alprazolam.
Why Alprazolam Carries a Distinctive Risk Profile
Not all benzodiazepines are alike. Alprazolam differs from longer-acting agents such as diazepam (Valium) or clonazepam (Klonopin) in three clinically meaningful ways:
- Short half-life (6–27 hours): The drug clears the body quickly, which means withdrawal symptoms can emerge within hours of a missed dose, making discontinuation feel acutely uncomfortable and reinforcing continued use.
- High potency per milligram: Alprazolam is among the most potent benzodiazepines available in standard clinical doses, meaning that even modest increases in dose can produce pronounced sedation and reinforce neurochemical changes tied to dependence.
- Rapid onset of anxiolytic effect: The fast-acting relief alprazolam provides can lead the nervous system to associate the drug strongly with relief from distress, which research suggests may accelerate psychological as well as physical dependence relative to slower-onset agents.
Benzodiazepine Use by the Numbers
The following figures, drawn from federal surveillance data, situate Xanax use disorder within a broader public health context.
How Xanax Dependence Develops
Alprazolam enhances the effect of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. Repeated exposure causes the brain to reduce its own GABA receptor sensitivity as a compensatory mechanism. Over time, the nervous system comes to rely on the drug to maintain what feels like baseline calm, and the absence of alprazolam is experienced as heightened excitability — which manifests as anxiety, insomnia, irritability, and, in severe cases, seizures.
Physical dependence is not the same as having a substance use disorder. A person can be physically dependent — meaning that stopping abruptly causes withdrawal — without meeting the clinical criteria for a benzodiazepine use disorder. Conversely, someone can develop compulsive, harmful patterns of use even when their physical dependence is relatively modest. Treatment planning should address both dimensions.
Xanax Withdrawal Timeline
Because of alprazolam’s short half-life, withdrawal can begin sooner than with many other benzodiazepines. The approximate progression below is based on clinical observation, though individual experience varies considerably depending on dose, duration of use, and physiological factors.
Clinical note on withdrawal safety: Abrupt discontinuation of Xanax following prolonged or high-dose use carries a risk of generalized tonic-clonic seizures, which can be life-threatening. Unlike opioid withdrawal, benzodiazepine withdrawal can be medically dangerous without proper supervision. Anyone considering stopping alprazolam should speak with a clinician before doing so. Medically supervised detoxification is typically the recommended starting point for moderate-to-severe dependence.
Frequently Asked Clinical Questions
The sections below address questions commonly raised by people and families in Tennessee who are trying to understand Xanax use disorder.
What is the difference between physical dependence and a Xanax use disorder?
▼
Physical dependence means the body has adapted to the presence of alprazolam and will produce withdrawal symptoms when the drug is reduced or stopped. This can happen even when a person takes the medication exactly as prescribed.
A substance use disorder, by contrast, involves a pattern of compulsive use that continues despite meaningful harm to a person’s health, relationships, or responsibilities. The DSM-5 outlines 11 diagnostic criteria for sedative, hypnotic, or anxiolytic use disorder; meeting two or more within a 12-month period indicates a diagnosis. Dependence alone does not meet this threshold.
Can a person overdose on Xanax alone?
▼
Benzodiazepine overdose from alprazolam alone is rarely fatal in otherwise healthy adults, though it causes significant sedation, respiratory depression, and cognitive impairment. The danger escalates dramatically when alprazolam is combined with alcohol, opioids, or other central nervous system depressants.
The CDC has documented that the majority of fatal overdoses involving benzodiazepines also involve at least one other substance. Tennessee’s own overdose prevention data reflects this polysubstance pattern. This is why polysubstance use assessment is a core part of any Xanax-related evaluation.
What happens to the brain with long-term alprazolam use?
▼
Prolonged use of alprazolam is associated with measurable changes in memory, attention, and processing speed. Some research suggests these cognitive effects are partially reversible following sustained abstinence, though the recovery timeline can extend over months to years. Older adults are particularly vulnerable because benzodiazepine use is independently associated with increased fall risk and has been studied in relation to dementia risk, though causality in the latter remains an area of active research.
People also frequently report that long-term use paradoxically worsens the anxiety they initially sought to treat — a phenomenon sometimes called benzodiazepine-induced neurological dysfunction, or BIND. This underscores why cognitive behavioral therapy (CBT) targeting anxiety is a critical component of Xanax use disorder treatment, not just the taper itself.
How is Xanax use disorder different in people who also have panic disorder?
▼
Panic disorder is one of the primary indications for alprazolam prescribing, and this creates a genuine clinical challenge: withdrawal-related anxiety and rebound panic can be indistinguishable from the underlying condition returning. People with co-occurring panic disorder often need a slower taper schedule — sometimes over many months — and concurrent evidence-based treatment for panic itself.
CBT, including panic-focused cognitive behavioral therapy and interoceptive exposure, has strong evidence as a non-pharmacological treatment for panic disorder and should be initiated alongside any medication taper when feasible. Motivational interviewing can also help people work through ambivalence about reducing a medication they associate with anxiety relief.
Is there a medication to treat Xanax withdrawal?
▼
There is no FDA-approved medication specifically for benzodiazepine withdrawal in the way that buprenorphine or methadone are approved for opioid use disorder. The standard clinical approach is a supervised, gradual taper — either directly reducing alprazolam or cross-tapering to a longer-acting benzodiazepine such as diazepam or chlordiazepoxide, which are cleared from the body more slowly and produce a smoother discontinuation curve.
Adjunct medications that clinicians sometimes use to manage specific symptoms during withdrawal include certain anticonvulsants (e.g., carbamazepine, gabapentin) and beta-blockers for autonomic symptoms such as rapid heartbeat and tremor. These are prescribed on a case-by-case basis within a medically supervised setting. Learn more about drug withdrawal management programs in Tennessee.
What does protracted withdrawal (PAWS) look like with Xanax?
▼
Post-acute withdrawal syndrome (PAWS) following benzodiazepine discontinuation is well-documented and can be particularly distressing for people who have used alprazolam at higher doses over extended periods. Symptoms tend to be intermittent rather than continuous and may include waves of anxiety, difficulty concentrating, emotional blunting, sleep disruption, and sensory hypersensitivity.
The unpredictability of PAWS can make early recovery challenging and is one reason why ongoing therapeutic support — through intensive outpatient programming or standard outpatient services — is valuable well beyond the initial detox period. Education about PAWS helps people understand that what they are experiencing has a known course and does not mean treatment is failing.
Co-Occurring Mental Health Conditions
Alprazolam is most commonly initiated for anxiety-related diagnoses, which means that people who develop Xanax use disorder frequently have a co-occurring anxiety or mood disorder. Treatment that addresses only the substance use while leaving underlying anxiety untreated significantly increases the likelihood of returning to use.
Conditions Frequently Co-occurring with Xanax Use Disorder
- Generalized anxiety disorder (GAD)
- Panic disorder with or without agoraphobia
- Social anxiety disorder
- Major depressive disorder
- Post-traumatic stress disorder (PTSD)
- Insomnia disorder
- Alcohol use disorder
- Opioid use disorder
Evidence-Based Therapies That Address Both
Treatment Program Levels for Xanax Use Disorder
The appropriate level of care depends on the severity of physical dependence, the presence of co-occurring conditions, the person’s social support network, and prior treatment history. The ASAM Criteria (published by the American Society of Addiction Medicine) provides the clinical framework most treatment programs in Tennessee use to make these determinations.
A Note on the Alprazolam Taper Approach
Because of alprazolam’s short half-life, many clinicians prefer to convert a person’s daily alprazolam dose to an equivalent dose of a longer-acting benzodiazepine — most commonly diazepam — and then reduce that medication gradually over weeks to months. This strategy tends to produce a smoother reduction with less inter-dose withdrawal discomfort.
The Ashton Manual, authored by the late pharmacologist Professor Heather Ashton, remains one of the most detailed clinical references for benzodiazepine tapering and is widely referenced by physicians and informed patients alike. However, any taper should be supervised by a licensed clinician who knows the individual’s full medical and psychiatric history.
Support Groups Specific to Benzodiazepine Recovery
General 12-step programs offer community and accountability that many people in recovery find valuable. However, the benzodiazepine-specific experience — particularly the long, variable withdrawal timeline and co-occurring anxiety — has led to the development of support groups that focus specifically on this substance class.
Nonprofit and Government Resources
Free, confidential, 24/7 referral and information service: 1-800-662-4357. Can help locate local treatment options for benzodiazepine use disorder.
Tennessee’s Department of Behavioral Health and Developmental Disabilities maintains a statewide network of publicly funded substance use disorder treatment providers.
Evidence-based research, treatment guides, and educational resources specifically addressing prescription sedatives and benzodiazepines.
Nonprofit offering therapist directories, self-help tools, and educational content for people managing anxiety disorders alongside or after medication dependence.
Related Substance Pages on Treatment Tennessee
Find Xanax Treatment Centers Near You in Tennessee
Treatment Tennessee connects individuals and families with vetted providers across the state. Use the location links below to explore listings in specific areas — many of which include providers experienced in medically supervised benzodiazepine tapers and co-occurring anxiety disorders.
Middle Tennessee
Murfreesboro
Clarksville
Columbia
Franklin
Cookeville
Smyrna
Springfield
Shelbyville
Lawrenceburg
Fayetteville
Dickson
Pulaski
Tullahoma
Antioch
Madison
Hohenwald
West Tennessee
Jackson
Dyersburg
Union City
Brownsville
Covington
Ripley
Savannah
Collierville
Bartlett
Millington
East Tennessee
Insurance Coverage for Xanax Use Disorder Treatment
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires that most insurance plans cover substance use disorder treatment at parity with medical/surgical benefits. Most Tennessee Medicaid (TennCare) plans cover medically necessary detox and residential treatment.
What to Expect When Seeking Treatment
Many people feel uncertain about what the process of entering treatment for Xanax use disorder actually looks like. Below is a general overview of the typical steps, though individual programs vary.
Assessment
A clinician reviews current alprazolam dose and duration of use, screens for co-occurring conditions, and uses the ASAM Criteria to recommend a level of care. This is typically done by phone or in person and takes 30–60 minutes.
Medical stabilization or structured taper
For those with moderate-to-severe dependence, this means entering a medically supervised detox setting where a physician manages the medication reduction under clinical observation.
Structured therapeutic programming
Following or alongside medical stabilization, therapeutic work begins — addressing the anxiety or other conditions that drove alprazolam use, building coping skills, and establishing relapse prevention strategies through evidence-based therapies.
Continuing care and community support
Ongoing outpatient therapy, peer support, sober living, and recovery coaching help sustain gains made in formal treatment and provide a safety net during the PAWS period, which can extend for months.
Ready to explore treatment options in Tennessee?
Use Treatment Tennessee’s directory to find providers experienced in benzodiazepine use disorder, medically supervised detox, and co-occurring anxiety treatment.
References and Citations
- National Institute on Drug Abuse. (2022). Prescription CNS Depressants Drug Facts. nida.nih.gov
- National Institute on Drug Abuse. (2021). Words Matter: Terms to Use and Avoid When Talking About Addiction. nida.nih.gov
- Centers for Disease Control and Prevention. (2023). Benzodiazepines and Opioid Overdose Deaths. cdc.gov
- Substance Abuse and Mental Health Services Administration. (2023). National Survey on Drug Use and Health (NSDUH). samhsa.gov
- Ashton, H. (2002). Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual). University of Newcastle. benzo.org.uk
- American Society of Addiction Medicine. (2023). The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. asam.org
- Lader, M. (2011). Benzodiazepines revisited—will we ever learn? Addiction, 106(12), 2086–2109. PubMed Central
- U.S. Drug Enforcement Administration. Benzodiazepines – Drug and Chemical Evaluation Section. DEA Diversion Control Division
- Tennessee Department of Mental Health and Substance Abuse Services. Overdose Prevention. tn.gov
- American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: APA. psychiatry.org
























































































